Remove 2009 Remove Collective Remove DEA Remove Safety
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Collectively, private investors have poured billions of dollars into these companies, with more money coming from non-profit organizations. Drug Enforcement Agency (“DEA”). Briefing is still under way, with the DEA’s responsive brief submitted on June 25, 2021, and the petitioners’ reply due July 16, 2021. AIMS Institute, PLLC.

Law 105
article thumbnail

Marijuana & Pregnancy: Top Studies

CannaMD

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CPA Journal Article: “Providing Services to the Marijuana Industry”

Cannabis Law Report

Since 2009, the Department of Justice has announced that it may not focus enforcement efforts on seriously ill individuals or their caregivers in states where marijuana cultivation and distribution for medical use is legalized; this guideline, however, was rescinded in 2018. Likewise, in Patients Mutual Assistance Collective Corp.

article thumbnail

Meadowlands: Update from Local Regulators with the Cannabis Czars of Los Angeles, San Francisco…

Meadow

I moved to San Francisco in 2006 and started my time in city government in 2009, so I spent over a decade in city hall working for two administrations. If you heard a couple weeks ago, maybe a month ago, DEA, FBI, IRS all came in Sacramento and they busted a whole bunch of homes. NICOLE: All right, I’ll start with me.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2(f)(1), May 20, 2009 , 123 Stat. 2(f)(2), May 20, 2009 , 123 Stat. 4) Federal receiver.—. . (A)

Banking 45